Awards
2022
Faculty Teaching Award for Pediatrics
Sponsor: Medical student class of 2023, University of Rochester
Location: Rochester, NY
2022
Make a Difference
Sponsor: Adolescent and young adult group 13Thirty cancer connect
Location: Rochester, NY
2021
Faculty Teaching Award for Pediatrics
Sponsor: Medical Student Class of 2022
Location: University of Rochester
2020 - 2020
Faculty Teaching Award for Pediatrics, presented by medical student class of 2021
Sponsor: University of Rochester
2017 - 2018
Faculty Teaching Award for Pediatrics, presented by medical student class of 2019
Sponsor: Pediatric and Medicine-Pediatric Residents Class of 2018
Location: University of Rochester Medical Center
2017 - 2017
Early Career Distinguished Service Award
Sponsor: The Rochester Academy of Medicine
Location: Rochester, New York
2016 - 2016
Young Investigator Award, travel stipend
Sponsor: Pediatric Blood and Marrow Tissue Consortium (PBMTC)
2015 - 2016
Ruth A. Lawrence Academic Faculty Service Award
Location: University of Rochester Medical Center
2015 - 2016
Faculty Teaching Award
Sponsor: Pediatric and Medicine-Pediatric Residents Class of 2016
Location: University of Rochester Medical Center
2015 - 2015
ICare Bronze Star Award
Sponsor: University of Rochester Medical Center
Location: Rochester, New York
2014 - 2015
Faculty Teaching Award for Pediatrics presented by UR Medicine Medical Student Class of 2016
Sponsor: University of Rochester Medical Center
Location: Rochester, New York
2013 - 2014
Faculty Teaching Award for Pediatrics
Sponsor: Medical Student Class of 2013
Location: University of Rochester Medical Center
2013 - 2014
Alpha Omega Alpha (AOA)
Sponsor: University of Rochester Medical Center
Location: Inducted into AOA by Medical Student Class of 2013
2012 - Present
Children's Oncology Group Primary Investigator (PI)
Sponsor: University of Rochester Medical Center
Location: Rochester, New York
2007
Resident Teaching Award
Location: Children's Memorial Hospital, Chicago, IL
2007
A. Todd Davis Physician Award
Location: Children's Memorial Hospital
2005
Resident Teaching Award
Location: Children's Memorial Hospital, Chicago, IL
2004
Gold Humanism in Medicine Honor Society
Location: University of Virginia School of Medicine
VIEW ALL expand_more
Clinical Trials
A Multi-Center, Phase 3, Randomized Trial of Matched Unrelated Donor (MUD) Versus HLA-Haploidentical Related (Haplo) Myeloablative Hematopoietic Cell Transplantation for Children, Adolescents, and Young Adults (AYA) With Acute Leukemia or Myelodysplastic Syndrome (MDS)
Lead Researcher: Jeffrey R Andolina
This phase III trial compares hematopoietic (stem) cell transplantation (HCT) using mismatched related donors (haploidentical \[haplo\]) versus matched unrelated donors (MUD) in treating children, adolescents, and young adults with acute leukemia or myelodysplastic syndrome (MDS). HCT is considered standard of care treatment for patients with high-risk acute leukemia and MDS. In HCT, patients are given very high doses of chemotherapy and/or radiation therapy, which is intended to kill cancer cells that may be resistant to more standard doses of chemotherapy; unfortunately, this also destroys the normal cells in the bone marrow, including stem cells. After the treatment, patients must have a healthy supply of stem cells reintroduced or transplanted. The transplanted cells then reestablish the blood cell production process in the bone marrow. The healthy stem cells may come from the blood or bone marrow of a related or unrelated donor. If patients do not have a matched related donor, doctors do not know what the next best donor choice is. This trial may help researchers understand whether a haplo related donor or a MUD HCT for children with acute leukemia or MDS is better or if there is no difference at all.
View Study Details
Analysis of Patients Treated for Chronic Granulomatous Disease Since January 1, 1995
Lead Researcher: Jeffrey R Andolina
Chronic granulomatous disease (CGD) is an inherited immune system abnormality in which bone marrow transplantation (BMT) has been shown to be curative. However the risks of transplantation are high and not all patients with CGD may need to undergo this high risk procedure. This study will determine the long term medical condition and daily functioning of participants with CGD after a transplant and if possible, compare these results to participants who do not undergo a transplant.
View Study Details
A Prospective Natural History Study of Diagnosis, Treatment and Outcomes of Children With SCID Disorders (RDCRN PIDTC-6901)
Lead Researcher: Jeffrey R Andolina
This study is a prospective evaluation of children with Severe Combined Immune Deficiency (SCID) who are treated under a variety of protocols used by participating institutions. In order to determine the patient, recipient and transplant-related variables that are most important in determining outcome, study investigators will uniformly collect pre-, post- and peri-transplant (or other treatment) information on all children enrolled into this study.
Children will be divided into three strata:
* Stratum A: Typical SCID with virtual absence of autologous T cells and poor T cell function
* Stratum B: Atypical SCID (leaky SCID, Omenn syndrome and reticular dysgenesis with limited T cell diversity or number and reduced function), and
* Stratum C: ADA deficient SCID and XSCID patients receiving alternative therapy including PEG-ADA ERT or gene therapy.
Each Group/Cohort Stratum will be analyzed separately.
View Study Details
Publications
Journal Articles
12/26/2022
Parisi R, Patel RR, Rood G, Bowden A, Turco G, Korones DN, Andolina JR, Comito M, Barth M, Weintraub L. "Multi-institution analysis of tumor mutational burden and outcomes in pediatric central nervous system tumor patients." Pediatric blood & cancer.. 2022 Dec 26; :e30139. Epub 2022 Dec 26.
11/28/2022
Dvorak CC, Haddad E, Heimall J, Dunn E, Cowan MJ, Pai SY, Kapoor N, Satter LF, Buckley RH, O'Reilly RJ, Chandra S, Bednarski JJ, Williams O, Rayes A, Moore TB, Ebens CL, Davila Saldana BJ, Petrovic A, Chellapandian D, Cuvelier GDE, Vander Lugt MT, Caywood EH, Chandrakasan S, Eissa H, Goldman FD, Shereck E, Aquino VM, Desantes KB, Madden LM, Miller HK, Yu L, Broglie L, Gillio A, Shah AJ, Knutsen AP, Andolina JP, Joshi AY, Szabolcs P, Kapadia M, Martinez CA, Parrot RE, Sullivan KE, Prockop SE, Abraham RS, Thakar MS, Leiding JW, Kohn DB, Pulsipher MA, Griffith LM, Notarangelo LD, Puck JM. "The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 Definitions." The Journal of allergy and clinical immunology.. 2022 Nov 28; Epub 2022 Nov 28.
8/1/2022
Fries C, Evans AG, Cheon H, Korones DN, Loughran TP, Andolina JR. "Allogeneic Bone Marrow Transplant as a Cure for Refractory T-Cell Large Granular Lymphocytic Leukemia in an Adolescent." Journal of pediatric hematology/oncology.. 2022 Aug 1; 44(6):e960-e963. Epub 2021 Dec 29.
Books & Chapters
2023
Chapter Title: Lymphadenopathy
Book Title: Signs and Symptoms in Pediatrics
Author List: Weinberg GA, Segel GB, and Andolina JR
Published By: American Academy of Pediatrics 2023
2019
Chapter Title: Solid Tumors and Leukemias
Book Title: Avery's Neonatology Board Review
Author List: Andolina, JR
Published By: Elsevier 2019
2019
Chapter Title: White Blood Cells
Book Title: Avery's Neonatology Board Review
Author List: Andolina, JR
Published By: Elsevier 2019
VIEW ALL PUBLICATIONS